Xeris Pharmaceuticals

$5.34
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.27 (-4.80%) Today

-$0.01 (-0.19%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell XERS and other stocks, options, and ETFs commission-free!

About XERS

Xeris Pharmaceuticals, Inc.is a pharmaceutical company, which develops and commercializes ready-to-use, liquid-stable injectables. It offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. The listed name for XERS is Xeris Pharmaceuticals, Inc. Common Stock.

CEO

Paul R. Edick

Employees

202

Headquarters

Chicago, Illinois

Founded

2005

Market Cap

250.37M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

2.14M

High Today

$5.67

Low Today

$5.25

Open Price

$5.67

Volume

1.38M

52 Week High

$7.16

52 Week Low

$1.42

Collections

XERS Earnings

-$1.28

-$0.85

-$0.43

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 11, Pre-Market